Immunovaccine Raises Total of $11.2 Million in Public Offering and Private Placement
September 04, 2014 09:22 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Sept. 4, 2014) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
Immunovaccine Inc....
Immunovaccine Upsizes and Prices Its Previously Announced Public Offering
August 26, 2014 14:09 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 26, 2014) -
NOT FOR DISTRIBUTION TO THE U.S. NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES
Immunovaccine Inc....
Ebola Vaccine Using Immunovaccine's DepoVax Proves Highly Efficacious in Non-Human Primate Study
August 25, 2014 10:30 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 25, 2014) - Immunovaccine Inc. ("Immunovaccine") (TSX VENTURE:IMV), a clinical stage vaccine company, today announced positive results for a...
Immunovaccine Announces Financial Results for Quarter Ended June 30, 2014
August 15, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 15, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
Immunovaccine to Present at Ninth Annual Immunotherapies and Vaccines Summit (ImVacS) Conference
August 12, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - Aug. 12, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, announced today that Marc Mansour,...
Immunovaccine Appoints Marc Mansour as Chief Executive Officer
June 11, 2014 09:18 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - June 11, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV" or "the Company") (TSX VENTURE:IMV), a clinical stage vaccine and immunotherapy company,...
Immunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014
June 02, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - June 2, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, presented positive results from a...
Immunovaccine Announces Financial Results for Quarter Ended March 31, 2014
May 28, 2014 17:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - May 28, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, today released its financial and...
Immunovaccine's Novel Immunotherapy Triggers Partial Response and Generates Potent Immune Responses in Ovarian Cancer Clinical Study
May 20, 2014 08:05 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - May 20, 2014) - Immunovaccine Inc. ("Immunovaccine" or "IMV") (TSX VENTURE:IMV), a clinical stage vaccine company, announced today that new positive...
Immunovaccine Clarifies May 12, 2014 Trading Activity
May 12, 2014 17:31 ET
|
Immunovaccine Inc.
HALIFAX, NOVA SCOTIA--(Marketwired - May 12, 2014) -
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES
Immunovaccine Inc. ("Immunovaccine" or...